Federal Official Gazette
ANS PUBLIC HEARING NOTICE No. 70, OF OCTOBER 7, 2026
ANS will hold, on Oct 16, 2026, from 9:30 a.m. to 12:30 p.m., a virtual public hearing on the preliminary recommendations not to include the following technologies in the Rol: somatrogon for children aged three and older and adolescents with growth hormone deficiency; and cabozantinib levomalate for adults with well-differentiated, unresectable, locally advanced or metastatic neuroendocrine tumors, previously treated with two or more therapies. Registration to participate must be completed by Oct 15, by 5 p.m. Submissions will be advisory in nature and will inform the Agency’s final decision.
ANS news
Public Consultation 178: ANS receives input on the update of the Rol
The National Supplementary Health Agency (ANS) opens, this Wednesday, Oct 7, Public Consultation 178, with the aim of obtaining input on the proposed updates to the List of Health Procedures and Events (Rol) for the following technologies: somatrogon, for the treatment of children aged 3 and older and adolescents with growth hormone deficiency (GHD); and cabozantinib levomalate, for the treatment of adult patients with well-differentiated, unresectable, locally advanced or metastatic neuroendocrine tumors, previously treated with two or more therapies. The technologies were approved to go to public consultation during the 12th Extraordinary Meeting of the Board of Directors of 2026, held on Oct 2.
644th Meeting of the Board of Directors
The meeting takes place this Friday (Oct 9), with live broadcast starting at 10 a.m. On the agenda:
DIPRO ITEM – CONSIDERATION of the proposed amendment to Normative Instruction ANS No. 31, which governs the monitoring and assessment of health plan operators’ guarantee of care to beneficiaries (Care Guarantee Monitoring). Case file: 33910.009781/2026-31. Analysis: the possible amendment to IN No. 31 deserves attention because it may change the methodology used to assess care-related complaints and identify products subject to suspension of sales. The agenda does not present the content of the amendment, so its effects can only be assessed after the decision and the publication of the approved draft.
OFF-AGENDA DIPRO ITEM – APPROVAL of the proposed update to the List of Health Procedures and Events. Outcome of the Public Consultation. Consideration of the Final Recommendation Technical Note – NTRF, relating to UAT No. 201. Approval of the proposed Normative Resolution. Case file No. 33910.018676/2026-93.
OFF-AGENDA DIFIS ITEM – APPROVAL of the proposal to enter into a Technical Cooperation Agreement between ANS and the REGIONAL FEDERAL COURT OF THE 5TH REGION – TRF5, under the Parceiros da Cidadania Program. Case file No. 33910.026708/2026-24
https://www.gov.br/ans/pt-br/arquivos/assuntos/noticias/Pauta_Dicol_644ANS09.10.2026.pdf
Treatment for biliary stones will be covered by health plans
The Board of Directors of the National Supplementary Health Agency (ANS) approved, on Oct 2, the inclusion of cholangioscopy with laser or electrohydraulic lithotripsy in the Rol of mandatory health plan coverage. The technology, used in the treatment of complex biliary stones, allows the destruction and removal of what are popularly called kidney stones, whether large or difficult to reach by the traditional method.
Open public consultations
CP 176. Subject: preliminary recommendations not to include the technology contained in UAT No. 184 – Molecular DNA analysis; search for microdeletions by FISH (Fluorescent In Situ Hybridization); microsatellite instability (MSI), detection by PCR, paraffin block, DUT SUBITEM – 110.39 – Syndrome of chromosomal abnormalities not clinically recognizable (array). Deadline: September 21 to October 10, 2026.
CP 178. Subject: preliminary recommendations not to include somatrogon and cabozantinib levomalate. Deadline: October 7 to 26, 2026.
Scheduled public hearings
AP 70. Subject: preliminary recommendations not to include somatrogon and cabozantinib levomalate, technologies submitted to public consultation 178. Date: Oct 16, from 9:30 a.m. to 12:30 p.m.
Open public calls for input
The call for input directed to operators’ ombudsman offices, concerning the effectiveness of service channels and the monitoring provided for in RN No. 623/2024, is open until Oct 20.
Open public calls
There are no open public calls or targeted social participation processes.
Other news
No updates.
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.